Cholangiokines: undervalued modulators in the hepatic microenvironment.

Prior research has shown that cholangiocytes primarily regulate bile transport and composition. However, their role in liver disease remains unclear. Established knowledge suggests bile ducts are passive structures in liver injury. No prior work had resolved how cholangiocytes might actively influence liver pathology. This gap motivated a closer examination of cholangiocyte secretions. That uncertainty drove investigation into their impact on inflammation and fibrosis. Recent studies suggest cholangiocytes may secrete factors affecting ductular proliferation. Yet, the full extent of these effects remains underexplored.

This review aims to clarify the role of cholangiocyte-secreted factors in liver disease. The specific problem is the lack of consensus on cholangiocyte function beyond bile transport. The motivation stems from recent findings suggesting these cells may influence fibrosis and cancer. The authors propose to synthesize evidence on cholangiokines in liver injury and regeneration. They suggest these mediators may modulate ductular cell behavior. The review focuses on how cholangiokines may affect inflammation and fibrosis. It also examines their role in malignant transformation. The goal is to highlight their potential as modulators in the hepatic microenvironment.

The authors conducted a literature review of cholangiocyte secretions in liver disease. They analyzed studies on cholangiokines in physiological and pathological contexts. The approach included examining how these mediators influence ductular cell proliferation. They compared findings across injury, regeneration, and fibrosis stages. The review focused on cytokine profiles under varying cellular states. They evaluated how quiescence, senescence, or proliferation affects secretion patterns. The authors synthesized evidence on cholangiokines' role in inflammation and fibrosis. They also assessed their involvement in carcinogenesis and liver regeneration.

Cholangiocytes release cytokines that may drive ductular cell proliferation. These secretions may influence portal inflammation and fibrosis. The authors report that cholangiokines vary depending on cellular states. They suggest these mediators may contribute to liver injury-regeneration cycles. The review highlights that cholangiocytes may modulate the hepatic microenvironment. Their secretions may promote malignant transformation in some contexts. The findings indicate that cholangiokines may act as modulators in liver disease. These results challenge the prior view of cholangiocytes as passive bystanders.

The authors propose that cholangiokines may modulate the hepatic microenvironment. They suggest these mediators may influence liver injury and regeneration processes. The review indicates that cholangiocytes may actively participate in fibrosis and inflammation. The authors synthesize evidence that cholangiokines may drive ductular cell proliferation. They propose that these secretions may affect portal inflammation and fibrosis. The findings suggest cholangiocytes may contribute to carcinogenesis. The authors conclude that cholangiokines may be undervalued modulators in liver disease. These insights may inform future research on cholangiocyte function in liver pathology.